CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹28 Cr | ₹23 Cr | ₹21 Cr | ₹17 Cr | ₹15 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CONCORD BIOTECH ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹28 Cr |
Mar2023 | ₹23 Cr |
Mar2022 | ₹21 Cr |
Mar2021 | ₹17 Cr |
Mar2020 | ₹15 Cr |
How is Deferred Tax Assets / Liabilities of CONCORD BIOTECH Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹28 Cr | 19.74 | |
Mar2023 | ₹23 Cr | 11.77 | |
Mar2022 | ₹21 Cr | 20.16 | |
Mar2021 | ₹17 Cr | 15.37 | |
Mar2020 | ₹15 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹18,197.3 Cr | -6.8% | -0.6% | 8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | -6.8% |
-0.6% |
8% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses